Portal de Periódicos da CAPES

Effect sizes and test-retest reliability of the fMRI-based neurologic pain signature

2021; Elsevier BV; Volume: 247; Linguagem: Inglês

10.1016/j.neuroimage.2021.118844

1095-9572

Xiaochun Han, Yoni K. Ashar, Philip A. Kragel, Bogdan Petre, Victoria Schelkun, Lauren Y. Atlas, Luke J. Chang, Marieke Jepma, Leonie Koban, Elizabeth A. Reynolds Losin, Mathieu Roy, Choong‐Wan Woo, Tor D. Wager,

Musculoskeletal pain and rehabilitation

Identifying biomarkers that predict mental states with large effect sizes and high test-retest reliability is a growing priority for fMRI research. We examined a well-established multivariate brain measure that tracks pain induced by nociceptive input, the Neurologic Pain Signature (NPS). In N = 295 participants across eight studies, NPS responses showed a very large effect size in predicting within-person single-trial pain reports (d = 1.45) and medium effect size in predicting individual differences in pain reports (d = 0.49). The NPS showed excellent short-term (within-day) test-retest reliability (ICC = 0.84, with average 69.5 trials/person). Reliability scaled with the number of trials within-person, with ≥60 trials required for excellent test-retest reliability. Reliability was tested in two additional studies across 5-day (N = 29, ICC = 0.74, 30 trials/person) and 1-month (N = 40, ICC = 0.46, 5 trials/person) test-retest intervals. The combination of strong within-person correlations and only modest between-person correlations between the NPS and pain reports indicate that the two measures have different sources of between-person variance. The NPS is not a surrogate for individual differences in pain reports but can serve as a reliable measure of pain-related physiology and mechanistic target for interventions.